TRDA: Entrada Therapeutics, Inc. Stock

by  •  • Comments Off on TRDA: Entrada Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 443.98
Enterprise Value ($M) 365.93
Book Value ($M) 422.45
Book Value / Share 11.93
Price / Book 1.05
NCAV ($M) 333.19
NCAV / Share 9.41
Price / NCAV 1.33

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.23

Liquidity (mrq)
Quick Ratio 6.59
Current Ratio 6.59

Balance Sheet (mrq) ($M)
Current Assets 465.33
Assets 554.59
Liabilities 132.14
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Price T Rowe Associates Inc /md/ 8.20 1.33
06-26 13D/A Baker Bros. Advisors Lp 13.20 3.43
02-14 13G/A Roche Finance Ltd 8.20 -2.47
02-14 13G/A Redmile Group, LLC 3.80 -30.76

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-17 27,189 85,186 31.92
2025-01-16 23,425 142,088 16.49
2025-01-15 19,298 100,244 19.25
2025-01-14 29,423 161,689 18.20

(click for more detail)

Similar Companies
TKNO – Alpha Teknova, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc. TRVI – Trevi Therapeutics, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io